腕式电子血压计

Search documents
风险偏好继续下降,北证短线交易指标已至绝对低位
Shenwan Hongyuan Securities· 2025-10-19 12:35
2025 年 10 月 19 日 x 险偏好继续下降, 机+得经 指标已至绝对低位 -北交所策略周报 (20251013-20251019) 本周策略观点: 本周市场行情: 北交所新股: 新三板动态: ● 本周新挂牌 10 家,摘牌 1 家,周新增计划融资 4.53 亿元,完成融资 1.66 亿元。 风险提示: 个股业绩季度波动过大风险,宏观经济下行的风险。 申万宏源研究微信服务号 目靖华 (8621)23297818× lvjh@swsresearch.com 请务必仔细阅读正文之后的各项信息披露与声明 品 相关研究 证券分析师 刘靖 A0230512070005 liujing@swsresearch.com 王雨晴 A0230522010003 wangyq@swsresearch.com 汪秉涵 A0230525090003 wangbh@swsresearch.com 郑菁华 A0230525060001 zhengjh@swsresearch.com 研究支持 目靖华 A0230124070002 lvjh@swsresearch.com 联系人 本周北证 50 下跌 4.91%,跌幅小于科创 5 ...
在家量血压,最容易忽略哪些细节?中疾控提示
Ren Min Wang· 2025-10-10 01:21
人民网北京10月10日电 (记者乔业琼)据中疾控微信公众号消息,家庭自测血压是高血压管理的 重要环节。通过自测血压,可以获得更准确的血压数据,为自身的健康管理和疾病预防提供有力支持。 关于家庭自测血压,需要注意以下内容。 选择合适的血压计 推荐使用上臂式电子血压计:这类血压计相对准确且易于操作,适合大多数人群。不推荐使用腕 式、手指式电子血压计或水银柱血压计。 确保血压计经过认证并定期校准:选择通过国家标准认证的血压计,以保证其测量精度。同时,每 年至少将血压计校准一次。 要按照正确的方法进行测量 准备阶段 环境要求:选择一个安静且温度适宜的房间进行测量血压,避免在寒冷或过热的环境中进行。 休息足够时间:在测量前,应静坐休息至少5分钟,同时,测量前的30分钟内应避免剧烈运动、进 食或饮用含咖啡因的饮品。 排空膀胱:由于充盈的膀胱可能会导致血压读数偏高,因此建议在测量血压前先去洗手间排空膀 胱。 测量姿势 正确坐姿:坐在有靠背的椅子上,背部挺直,双脚平放在地面,不要交叉双腿。 手臂位置:测量时,应确保裸露的上臂中心点与心脏处于同一水平线上。袖带的下缘应位于肘窝上 方2.5厘米处,且松紧度要适中,以能够插入1-2 ...
21健讯Daily | 国家药监局通报4起医疗器械网络销售违法违规案件;港股映恩生物盘中涨幅扩大至130%
2 1 Shi Ji Jing Ji Bao Dao· 2025-04-16 01:09
Regulatory Developments - The National Medical Products Administration reported four cases of illegal online sales of medical devices, emphasizing a "zero tolerance" regulatory attitude to ensure safety in medical device usage [2] - Companies involved include Jiangyin Tianyu Medical Device Co., Yiwu Shenghe Medical Device Co., Shanghai Yile Warehouse Medical Device Co., and Hefei Baohua Design Studio, all of which failed to comply with regulatory requirements [2] Industry Advancements - Hangzhou is accelerating the development of medical artificial intelligence applications, aiming to establish a national AI (medical) application pilot base and create intelligent medical entities focused on various health management areas [3] - The city plans to build digital health innovation laboratories to advance key technologies in medical AI [3] Company Announcements - Leksin Medical received a medical device registration certificate for its wrist-type electronic blood pressure monitor from the Guangdong Provincial Drug Administration [5] - David Medical's wholly-owned subsidiary, Ningbo Yongxing Medical Instruments Co., obtained a medical device registration certificate for a linear cutting stapler used in various surgical procedures [6] - Warner Pharmaceuticals announced the approval of its drug registration certificate for the injection of methoxamine hydrochloride, used for treating acute hypotension during spinal anesthesia [7] Financial Reports - Guobang Pharmaceutical reported a revenue of 1.44 billion yuan for Q1 2025, a year-on-year increase of 7.57%, with a net profit of 215 million yuan, up 8.17% [9] - Johnson & Johnson's Q1 sales reached 21.89 billion dollars, with an annual sales forecast of 91 to 91.8 billion dollars and adjusted earnings per share projected between 10.50 and 10.70 dollars [10] Market Movements - In Hong Kong, InnoCare's stock surged by 130% on its first trading day [12] - Darentang announced plans to transfer a 12% stake in China-US Tianjin Schering Pharmaceutical Co., with estimated investment income of approximately 1.54 billion yuan from the transaction [13] - Nanjing Noling Biotechnology completed a C-round financing of several hundred million yuan, led by Dingxin Capital [14] Collaborative Initiatives - Berry Genomics' subsidiary signed a project cooperation framework agreement with Beijing Children's Hospital to promote clinical transformation and commercialization of research outcomes related to newborn screening technologies [16] - Bangyan Technology plans to officially launch its AI Agent product this year, aimed at assisting digital transformation in the healthcare sector [17] Personnel Changes - Bell Bio's financial officer, Zhao Baozhen, resigned for personal reasons but will continue to serve as the board secretary [19]